C4 Therapeutics, Inc. (CCCC)
3.49
-0.02
(-0.57%)
USD |
NASDAQ |
Sep 14, 10:52
C4 Therapeutics 1 Year Total Returns (Daily) : 28.57% for Sept. 11, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 11, 2026 | 28.57% |
| September 10, 2026 | 28.79% |
| September 09, 2026 | 28.36% |
| September 08, 2026 | 31.00% |
| September 04, 2026 | 40.82% |
| September 03, 2026 | 46.09% |
| September 02, 2026 | 51.00% |
| September 01, 2026 | 48.85% |
| August 31, 2026 | 42.69% |
| August 28, 2026 | 50.98% |
| August 27, 2026 | 58.91% |
| August 26, 2026 | 64.98% |
| August 25, 2026 | 66.01% |
| August 24, 2026 | 57.09% |
| August 21, 2026 | 53.26% |
| August 20, 2026 | 55.00% |
| August 19, 2026 | 52.54% |
| August 18, 2026 | 46.15% |
| August 17, 2026 | 73.37% |
| August 14, 2026 | 80.43% |
| August 13, 2026 | 75.11% |
| August 12, 2026 | 74.11% |
| August 11, 2026 | 59.92% |
| August 10, 2026 | 44.80% |
| August 07, 2026 | 44.57% |
| Date | Value |
|---|---|
| August 06, 2026 | 85.71% |
| August 05, 2026 | 80.10% |
| August 04, 2026 | 71.90% |
| August 03, 2026 | 65.09% |
| July 31, 2026 | 69.76% |
| July 30, 2026 | 69.44% |
| July 29, 2026 | 56.44% |
| July 28, 2026 | 62.84% |
| July 27, 2026 | 58.85% |
| July 24, 2026 | 48.47% |
| July 23, 2026 | 50.83% |
| July 22, 2026 | 68.47% |
| July 21, 2026 | 68.72% |
| July 20, 2026 | 54.31% |
| July 17, 2026 | 69.27% |
| July 16, 2026 | 77.23% |
| July 15, 2026 | 80.09% |
| July 14, 2026 | 60.08% |
| July 13, 2026 | 75.78% |
| July 10, 2026 | 104.0% |
| July 09, 2026 | 112.4% |
| July 08, 2026 | 145.0% |
| July 07, 2026 | 186.2% |
| July 06, 2026 | 179.7% |
| July 02, 2026 | 182.9% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Beam Therapeutics, Inc. | 11.32% |
| Rallybio Corp. | 256.6% |
| Q32 Bio, Inc. | 490.4% |
| Arrowhead Pharmaceuticals, Inc. | 178.8% |
| Oncolytics Biotech, Inc. | -43.09% |